UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) – February 13, 2006
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
|
Pennsylvania |
|
1-8036 |
|
23-1210010 |
|
(State or
other jurisdiction |
|
(Commission File Number) |
|
(IRS
Employer |
|
|
|
|
|
|
|
101 Gordon Drive, PO Box 645, |
|
19341-0645 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
610-594-3319
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01 |
|
Entry into a Material Definitive Agreement |
|
|
|
|
|
|
|
On February 13, 2006, the Compensation Committee of the Board of Directors of West Pharmaceutical Services, Inc. (the “Company”) established the financial-performance targets for the 2006 Management Annual Incentive Bonus Plan. All of the Company’s named executive officers (as defined in Item 402(a)(3) of Regulation S-K, promulgated by the Securities and Exchange Commission) participate in this plan. A copy of the summary of this plan is attached attached as Exhibit 99.1 hereto. |
|
Item 9.01 |
|
Financial Statements and Exhibits |
|
|
|
|
|
(c) |
|
Exhibits |
|
|
|
|
|
Exhibit # |
|
Description |
|
99.1 |
|
Summary of 2006 Management Annual Incentive Bonus Compensation Plan |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
WEST PHARMACEUTICAL SERVICES, INC. |
|
|
|
|
|
|
|
/s/ John R. Gailey III |
|
|
|
John R. Gailey III |
|
|
|
Vice President, General Counsel and Secretary |
|
|
|
|
|
|
|
|
|
|
February 17, 2006 |
|
|
3